Apogem Capital’s 1Life Healthcare ONEM Stock Holding History

Apogem Capital’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-53,931	Closed	-$423K	–	172
2022 Q2	$423K	Buy	+53,931	New	+$463K	0.38%	85

Other funds holding ONEM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SHG

Sheares Healthcare Group Singapore $1.69M AUM 4.89% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

OMC

Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Apogem Capital's ONEM Position: Q3 2022 in Review

Apogem Capital sold out of 1Life Healthcare (ONEM) in Q3 2022, closing a stake of 53,931 shares — an estimated $423K sold.

Apogem Capital first reported a position in ONEM in Q2 2022 and held it in 1 quarter. The position peaked at $423K in Q2 2022. 222 funds tracked by Wall St. Rank hold ONEM as of Q3 2022.

Apogem Capital reported no remaining 1Life Healthcare position as of Q3 2022 after selling out during the quarter.
Apogem Capital sold 53,931 1Life Healthcare shares in Q3 2022, an estimated $423K.
Apogem Capital first reported a position in 1Life Healthcare in Q2 2022 and held it in 1 quarter.
Apogem Capital's 1Life Healthcare position peaked at $423K in Q2 2022.
222 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2022.

Based on Apogem Capital's 13F filing for Q3 2022, filed 14 Nov 2022.